Skip to Main Content

Paper Details

Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy.
Nat Med
65
2020
ICB, cancer, human, immunocompetent models, melanocytic plasticity signature, melanoma, melanomas, mouse, patient, patients, syngeneic mouse models, tumor, tumor-infiltrating immune cell
Author NameAffiliation
Eva P??rez-GuijarroCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Eva P??rez-GuijarroCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Howard H YangCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Howard H YangCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Helen T MichaelCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Helen T MichaelCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Kerrie L MarieCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Kerrie L MarieCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Aleksandra M MichalowskiCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Aleksandra M MichalowskiCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Nicholas P RestifoCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Nicholas P Restifo
Nicholas P RestifoCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Nicholas P Restifo
Maxwell P LeeCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Maxwell P LeeCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Chi-Ping DayCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Chi-Ping DayCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Glenn MerlinoCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Glenn MerlinoCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 20

Datasets